354
Views
17
CrossRef citations to date
0
Altmetric
Articles

Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE)

, , , , , , , , , , & show all
Pages 1457-1468 | Received 25 Jul 2015, Accepted 20 Apr 2016, Published online: 16 May 2016

References

  • Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., … Wojna, V. E. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69, 1789–1799.10.1212/01.WNL.0000287431.88658.8b
  • Brouillette, M. J., Mayo, N., Fellows, L. K., Lebedeva, E., Higgins, J., Overton, E. T., … Koski, L. (2015). A better screening tool for HIV-associated neurocognitive disorders. AIDS, 29, 895–902. doi:10.1097/QAD.0000000000000152
  • Caffarra, P., Vezzadini, G., Dieci, F., Zonato, F., & Venneri, A. (2002). Una versione abbreviata del test di Stroop. Dati normativi nella popolazione italiana [A brief version of the Stroop test. Normative data for an Italian population]. Nuova Rivista di Neurologia, 12, 111–115.
  • Capitani, E., & Laiacona, M. (1997). Composite neuropsychological batteries and demographic correction: Standardization based on equivalent scores, with a review of published data. The Italian group for the neuropsychological study of Ageing. Journal of Clinical and Experimental Neuropsychology, 19, 795–809.10.1080/01688639708403761
  • Carlesimo, G. A., Caltagirone, C., & Gainotti, G. (1996). The mental deterioration battery: Normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The group for the standardization of the mental deterioration battery. European Neurology, 36, 378–384.10.1159/000117297
  • Chan, L. G., Kandiah, N., & Chua, A. (2012). HIV-associated neurocognitive disorders (HAND) in a South Asian population – Contextual application of the 2007 criteria. BMJ Open, 2, e000662. doi:10.1136/bmjopen-2011-000662
  • Ciccarelli, N., Fabbiani, M., Baldonero, E., Fanti, I., Cauda, R., Di Giambenedetto, S., & Silveri, M. C. (2012). Effect of aging and human immunodeficiency virus infection on cognitive abilities. Journal of American Geriatric Society, 60, 2048–2055. doi:10.1111/j.1532-5415.2012.04213.x
  • Ciccarelli, N., Fabbiani, M., Colafigli, M., Trecarichi, E. M., Silveri, M. C., Cauda, R., … Di Giambenedetto, S. (2013). Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia. Antiviral Therapy, 18, 153–160. doi:10.3851/IMP2560
  • Ciccarelli, N., Fabbiani, M., Di Giambenedetto, S., Fanti, I., Baldonero, E., Bracciale, L., … Silveri, M. C. (2011). Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology, 76, 1403–1409. doi:10.1212/WNL.0b013e31821670fb
  • Cullum, C. M., Thompson, L. L., & Smernoff, E. N. (1993). Three-word recall as a measure of memory. Journal of Clinical and Experimental Neuropsychology, 15, 321–329.10.1080/01688639308402566
  • Cysique, L. A., Vaida, F., Letendre, S., Gibson, S., Cherner, M., Woods, S. P., … Ellis, R. J. (2009). Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology, 73, 342–348. doi:10.1212/WNL.0b013e3181ab2b3b
  • Fabbiani, M., Ciccarelli, N., Tana, M., Farina, S., Baldonero, E., Di Cristo, V., … Di Giambenedetto, S. (2013). Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. HIV Medicine, 14, 136–144. doi:10.1111/j.1468-1293.2012.01044.x
  • Garvey, L., Surendrakumar, V., & Winston, A. (2011). Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy. HIV Clinical Trials, 12, 333–338. doi:10.1310/hct1206-333
  • Giovagnoli, A. R., Del Pesce, M., Mascheroni, S., Simoncelli, M., Laiacona, M., & Capitani, E. (1996). Trail making test: Normative values from 287 normal adult controls. The Italian Journal of Neurological Sciences, 17, 305–309.10.1007/BF01997792
  • Gisslen, M., Price, R. W., & Nilsson, S. (2011). The definition of HIV-associated neurocognitive disorders: Are we overestimating the real prevalence? BMC Infectious Diseases, 11(1), 1. doi:10.1186/1471-2334-11-356
  • Hasbun, R., Eraso, J., Ramireddy, S., Wainwright, D. A., Salazar, L., Grimes, R., … Strutt, A. (2012). Screening for neurocognitive impairment in HIV individuals: The utility of the montreal cognitive assessment test. Journal of AIDS & Clinical Research, 3, 186. doi:10.4172/2155-6113.1000186
  • Heaton, R. K., Clifford, D. B., Franklin, D. R., Jr., Woods, S. P., Ake, C., Vaida, F., … CHARTER Group. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75, 2087–2096. doi:10.1212/WNL.0b013e318200d727
  • Heaton, R. K., Franklin, D. R., Ellis, R. J., McCutchan, J. A., Letendre, S. L., Leblanc, S., … HNRC Group. (2011). HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. Journal of Neurovirology, 17, 3–16. doi:10.1007/s13365-010-0006-1
  • Kim, W. J., Ku, N. S., Lee, Y. J., Ahn, J. Y., Kim, S. B., Ahn, H. W., … Kim, E. (2016). Utility of the Montreal Cognitive Assessment (MoCA) and its subset in HIV-associated neurocognitive disorder (HAND) screening. Journal of Psychosomatic Research, 80, 53–57. doi:10.1016/j.jpsychores.2015.11.006
  • Koski, L., Brouillette, M. J., Lalonde, R., Hello, B., Wong, E., Tsuchida, A., & Fellows, L. (2011). Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment(*). HIV Medicine, 12, 472–480. doi:10.1111/j.1468-1293.2010.00910.x
  • Ku, N. S., Lee, Y., Ahn, J. Y., Song, J. E., Kim, S. B., Jeong, S. J., … Choi, J. Y. (2014). HIV-associated neurocognitive disorder in HIV-infected Koreans: The Korean NeuroAIDS Project. HIV Medicine, 15, 470–477. doi:10.1111/hiv.12137
  • Lawton, M. P., & Brody, E. M. (1969). Assessment of older people: Self-maintaining and instrumental activities of daily living. The Gerontologist, 9, 179–186.10.1093/geront/9.3_Part_1.179
  • Letendre, S., FitzSimons, C., Ellis, R. J., Clifford, D., Collier, A. C., Gelman, B., … CHARTER Group. (2010, February). Correlates of CSF viral loads in 1221 volunteers of the CHARTER Cohort. Poster session presented at the 17th Conference on Retrovirus and Opportunistic Infections, San Francisco, CA, USA.
  • Lovejoy, T. I., & Suhr, J. A. (2009). The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: A systematic review. Journal of Behavioral Medicine, 32, 389–405. doi:10.1007/s10865-009-9212-9
  • Lovibond, S. H., & Lovibond, P. F. (1995). Manual for depression anxiety stress scales (2nd ed.). Sydney: Psychology Foundation.
  • Measso, G., Cavarzeran, F., Zappalà, G., Lebowitz, B., Crook, T., Pirozzolo, F., … Grigoletto, F. (1993). The mini-mental state examination: Normative study of an Italian random sample. Developmental Neuropsychology, 9, 77–85. doi:10.1080/87565649109540545
  • Milanini, B., Wendelken, L. A., Esmaeili-Firidouni, P., Chartier, M., Crouch, P. C., & Valcour, V. (2014). The Montreal Cognitive Assessment to screen for cognitive impairment in HIV patients older than 60 years. Journal of Acquired Immune Deficiency Syndromes, 67, 67–70. doi:10.1097/QAI.0000000000000220
  • Mind Exchange Working Group. (2013). Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: A consensus report of the mind exchange program. Clinical Infectious Diseases, 56, 1004–1017. doi:10.1093/cid/cis975
  • Monaco, M., Costa, A., Caltagirone, C., & Carlesimo, G. A. (2013). Forward and backward span for verbal and visuo-spatial data: Standardization and normative data from an Italian adult population. Neurological Sciences, 34, 749–754. doi:10.1007/s10072-012-1130-x
  • Muñoz-Moreno, J. A., Prats, A., Pérez-Álvarez, N., Fumaz, C. R., Garolera, M., Doval, E., … NEU Study Group. (2013). A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: The NEU screen. Journal of Acquired Immune Deficiency Syndromes, 63, 585–592. doi:10.1097/QAI.0b013e31829e1408
  • Nasreddine, Z. S., Phillips, N. A., Bedirian, V., Charbonneau, S., Whitehead, V., Collin, I. … Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53, 695–699.10.1111/jgs.2005.53.issue-4
  • Nightingale, S., Winston, A., Letendre, S., Michael, B. D., McArthur, J. C., Khoo, S., & Solomon, T. (2014). Controversies in HIV-associated neurocognitive disorders. The Lancet Neurology, 13, 1139–1151. doi:10.1016/S1474-4422(14)70137-1
  • Orsini, A., & Laicardi, C. (1997). WAIS-R. Contributo alla taratura italiana [WAIS-R. Contribution to the Italian normative data]. Firenze: O.S. Organizzazione Speciali.
  • Overton, E. T., Azad, T. D., Parker, N., Demarco Shaw, D., Frain, J., Spitz, T., & Ances, B. M. (2013). The Alzheimer’s disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons. Journal of Neurovirology, 19, 109–116. doi:10.1007/s13365-012-0147-5
  • Palella, F. J., Jr., Baker, R. K., Moorman, A. C., Chmiel, J. S., Wood, K. C., Brooks, J. T., … HIV Outpatient Study Investigators. (2006). Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study. Journal of Acquired Immune Deficiency Syndromes, 43, 27–34.10.1097/01.qai.0000233310.90484.16
  • Power, C., Selnes, O. A., Grim, J. A., & McArthur, J. C. (1995). HIV Dementia Scale: A rapid screening test. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 8, 273–278.10.1097/00042560-199503010-00008
  • Robbins, R. N., Joska, J. A., Thomas, K. G., Stein, D. J., Linda, T., Mellins, C. A., & Remien, R. H. (2013). Exploring the utility of the Montreal Cognitive Assessment to detect HIV-associated neurocognitive disorder: The challenge and need for culturally valid screening tests in South Africa. The Clinical Neuropsychologist, 27, 437–454. doi:10.1080/13854046.2012.759627
  • Sacktor, N. C., Wong, M., Nakasujja, N., Skolasky, R. L., Selnes, O. A., Musisi, S., … Katabira, E. (2005). The International HIV Dementia Scale: A new rapid screening test for HIV dementia. AIDS, 19, 1367–1374.
  • Sakamoto, M., Marcotte, T. D., Umlauf, A., Franklin, D., Jr., Heaton, R. K., Ellis, R. J., … CHARTER Group. (2013). Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. Journal of Acquired Immune Deficiency Syndromes, 62, 36–42. doi:10.1097/QAI.0b013e318278ffa4
  • Santangelo, G., Siciliano, M., Pedone, R., Vitale, C., Falco, F., Bisogno, R., … Trojano, L. (2015). Normative data for the Montreal Cognitive Assessment in an Italian population sample. Neurological Sciences, 36, 585–591. doi:10.1007/s10072-014-1995-y
  • Simioni, S., Cavassini, M., Annoni, J. M., Rimbault Abraham, A., Bourquin, I., Schiffer, V., … Du Pasquier, R. A. (2010). Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS, 24, 1243–1250. doi:10.1097/QAD.0b013e3283354a7b
  • Skinner, S., Adewale, A. J., DeBlock, L., Gill, M. J., & Power, C. (2009). Neurocognitive screening tools in HIV/AIDS: Comparative performance among patients exposed to antiretroviral therapy. HIV Medicine, 10, 246–252. doi:10.1111/j.1468-1293.2008.00679.x
  • Torti, C., Focà, E., Cesana, B. M., & Lescure, F. X. (2011). Asymptomatic neurocognitive disorders in patients infected by HIV: Fact or fiction? BMC Medicine, 9(1), 1. doi:10.1186/1741-7015-9-138
  • Trites, R. L. (1977). Neuropsychological Test Manual. Ottawa: Royal Ottawa Hospital.
  • Valcour, V., Paul, R., Chiao, S., Wendelken, L. A., & Miller, B. (2011). Screening for cognitive impairment in human immunodeficiency virus. Clinical Infectious Diseases, 53, 836–842. doi:10.1093/cid/cir524
  • Valcour, V. G. (2011). Evaluating cognitive impairment in the clinical setting: Practical screening and assessment tools. Topics in Antiviral Medicine, 19, 175–180.
  • Woods, S. P., Moore, D. J., Weber, E., & Grant, I. (2009). Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychology Review, 19, 152–168. doi:10.1007/s11065-009-9102-5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.